Naymisha Patel
About Naymisha Patel
Senior Vice President, Quality
Naymisha (Isha) Patel holds the title of Senior Vice President, Quality. With more than 25 years of industry experience, Patel has played a pivotal role in establishing and enhancing quality functions for various therapeutic sectors, including cell and gene therapies. She is recognized for her expertise in quality management, compliance, and building robust quality systems from the ground up.
Industry Experience in Quality and Compliance
Over her extensive career, Patel has amassed significant experience in quality and compliance. Most recently, she served as Vice President, Quality, at Evolus Inc., where she strengthened quality systems to support the global commercialization of medical aesthetic products. Her past roles include leadership positions at Ocular Therapeutics, Prothena, StemCells, Geron, and Nektar Therapeutics, showcasing her broad expertise across multiple organizations.
Education and Degrees
Patel earned a Bachelor of Science (B.S.) degree from Maharaja Sayajirao (MS) University in India. She also holds a Bachelor of Arts (B.A.) from California State University and a Master of Business Administration (MBA) from Northcentral University. These educational qualifications have equipped her with a strong foundation in both scientific and business disciplines, enabling her to excel in her professional roles.
Leadership at Evolus Inc.
At Evolus Inc., Patel made significant contributions as the Vice President, Quality. Her efforts were focused on strengthening quality systems, which were crucial for the global commercialization of the company's medical aesthetic products. Her role involved ensuring that the products met all regulatory and compliance standards, thereby facilitating their successful entry into the global market.
Building Quality Functions for Diverse Therapeutics
Throughout her career, Patel has been dedicated to building quality functions from the ground up for a variety of therapeutic areas, including cell and gene therapies. Her work involves developing and implementing quality management systems tailored to the specific needs of these advanced therapeutic products, ensuring they meet rigorous industry standards and regulatory requirements.